Pre-Market Movers: Top 5 Stocks Making Biggest Moves Before the Bell Today (May 18)

The pre-market is setting up for a volatile Monday open on May 18, 2026. Five major movers are already printing significant moves in after-hours and early morning trading, driven by earnings surprises, guidance revisions, and macroeconomic signals. NVIDIA is up 6.2% to $127.44 on 2.1M shares (vs. 890K pre-market average), Tesla is down 4.8% to $198.33 on 3.4M shares, and three other Tier 1 names are seeing outsized volume ahead of the 9:30 a.m. ET open.

Understanding what's driving pre-market moves is critical for traders and investors. These early movers often establish the tone for the full trading session, setting resistance and support levels that hold through the close. Let's break down the five biggest pre-market movers and what catalysts are behind them.

What's Driving Pre-Market Stock Moves Today

Pre-market trading reflects overnight news, international market closes, and investor positioning ahead of the open. On May 18, the five biggest movers are responding to company-specific catalysts rather than broad macro shifts.

NVIDIA (NVDA) is printing a 6.2% gain to $127.44 after Morgan Stanley released a note late Sunday flagging stronger-than-expected data center chip orders through Q3 2026. The firm cited channel checks indicating hyperscaler capex acceleration, particularly from a major AI infrastructure provider Morgan Stanley declined to name. This confirms what NVDA stock bulls have been betting on: the AI buildout isn't slowing. Pre-market volume already stands at 2.1M shares—more than double the typical pre-market average for NVIDIA. The stock last moved this size on February 12, 2026, when it surged 7.1% after a better-than-expected data center revenue forecast.

Tesla (TSLA) is down 4.8% to $198.33 after the company issued overnight guidance, cutting FY2026 deliveries to 1.58M units from the prior 1.8M consensus. Management cited production delays at the Berlin factory (pushing output back by 8 weeks) and softer-than-expected demand in Europe. This is TSLA's second guidance cut in 90 days, a red flag that concerns bears who argue the premium valuation (22x forward earnings) isn't justified given macro headwinds. Pre-market sellers are positioned ahead of the open; volume is already 3.4M shares. The stock hasn't printed a move this large since March 15, when it fell 5.2% on similar delivery misses.

Pfizer (PFE) gained 3.1% to $32.18 in pre-market after announcing positive Phase 3 data for its next-generation lung cancer therapy (PF-06944650). The trial met primary endpoints, showing a 34% reduction in progression or death versus standard of care. This de-risks a key pipeline asset. Pfizer now has two blockbuster-track cancer therapies in late-stage development, potentially adding $4B+ in peak sales. Pre-market volume is tracking 1.8M shares, normal for pharmaceutical pre-market.

Eli Lilly (LLY) fell 2.4% to $921.66 after a supply chain update indicated potential manufacturing delays for its GLP-1 obesity drug. Management signaled Q4 production will come in 15% below internal targets due to equipment upgrades at Indianapolis. This doesn't change long-term demand (LLY guidance still calls for $12B+ in obesity drug revenue by 2030), but near-term margin pressure is real. The stock has outperformed 44% year-to-date; profit-takers are using this update as an exit signal. Volume is tracking 890K shares in pre-market.

AMD (AMD) is up 2.1% to $187.42 after JPMorgan flagged accelerating data center GPU adoption in a Monday morning note. The firm points to competitive wins against NVIDIA in specific workloads (inference, not training), suggesting AMD could capture 8-10% of the incremental AI chip market by 2027, versus 5% prior estimates. This is more modest than NVIDIA's rally but meaningful for a company fighting for relevance in AI infrastructure. Pre-market volume is 1.2M shares.

NVDA Stock Key Levels to Watch at the Open

NVIDIA is trading at $127.44 in pre-market, up 6.2% from Friday's close of $120.00. Traders should watch these critical levels when the market opens at 9:30 a.m. ET:

Resistance: $130.00 is the first hard resistance—the stock printed an intraday high of $130.15 on May 1 during the last earnings-driven surge. Above that, $133.50 is the 52-week high from March 14. Below $130, sellers often step in.

Support: $125.00 is the 50-day moving average and a critical support zone. If pre-market momentum fades at the open and profit-taking accelerates, $125 is where technical buyers will step in. Below that, $122.00 (the 200-day MA) is the next major support.

Volume context: Friday's close saw 45.2M shares, just above the 30-day average of 42.1M. If pre-market gains hold and the stock opens near $127, expect volume to spike 60-80M shares as momentum traders chase and shorts cover. The biggest volume spike would suggest the move is structural, not a dead-cat bounce.

TSLA Stock Key Levels to Watch at the Open

Tesla is at $198.33 in pre-market, down 4.8% from Friday's $208.50 close. Key levels:

Support: $195.00 is the first support zone—the stock tested this on May 5 and held. Below that, $190.00 is the 50-day MA. If sellers panic and the stock breaks $190, the next floor is $185.00 (200-day MA, the level where bulls backed up the truck in late February).

Resistance: $205.00 is where short-covering could emerge if the stock bounces from the open. $210.00 is Friday's close level—if the stock gets back there, it would signal the guidance miss was already priced in.

Volume watch: Friday saw 52.1M shares on neutral action. This morning, pre-market is tracking 3.4M shares already—expect 85-100M shares at the open as investors react to guidance. Heavy volume on a decline typically indicates capitulation, which can be a reversal signal.

What Analysts Say About Pre-Market Movers

The analyst consensus is split on how to interpret Monday's pre-market action.

On NVIDIA: 24 analysts cover the stock with an average price target of $145.00 (14% upside from pre-market). Morgan Stanley just reiterated Overweight with a $155 target. Goldman Sachs, however, issued a note of caution Friday, arguing that data center capex may normalize in H2 2026—the only Sell-rated analyst on the Street. The bull case: data center capex accelerates through 2027 as AI training clusters scale. The bear case: valuations have gotten extended at 45x forward earnings, and any disappointment could trigger a 15-20% correction.

On Tesla: 18 analysts cover the stock with an average price target of $215.00 (8.4% upside from pre-market, but this was calculated before the guidance cut). Citi downgraded to Neutral on May 15 (before this guidance), citing valuation and macro headwinds. Only 10 of 18 analysts maintain Buy or Overweight ratings. The margin compression from lower volume is real—Tesla can't leverage fixed costs effectively if deliveries miss by 200K units. Expect downgrades from the Citi/UBS bull camp within 24 hours.

On Pfizer: The Phase 3 win is significant. Stifel maintained Buy with a $38 target (18% upside), citing the cancer portfolio momentum. This is a low-bar beat for pharma—most PFE bulls were already assuming this drug would succeed.

What's Next for Pre-Market Movers

The real test for these pre-market moves comes at the open. Pre-market volume is thin (roughly 15-20% of typical daily volume), meaning moves are often exaggerated. Here's what to watch:

NVIDIA: Next catalyst is NVDA's investor day on June 10, where management is expected to detail H100 successor chips and new AI software. If the Morgan Stanley data is legit, guidance could see upward revision. Bull target: $150 by end of June. Bear target: $110 if macro deteriorates.

Tesla: Q1 2026 earnings call is May 22, where Elon Musk will address the delivery miss and likely cut forward guidance again. If TSLA drops below $190 at the open and stays there, the shorts will be emboldened. Bull case: demand rebounds in June after a spring sales pause (cyclical). Bear case: TSLA loses share to new EV competitors, and the premium valuation unwind accelerates.

Pfizer: Next catalyst is earnings on May 28. Pharma investors will want to hear updated cancer franchise guidance. Bull case: $40 by July on pipeline strength. Bear case: vaccine segment continues to decline post-COVID.

Eli Lilly: Earnings are May 28. Supply chain update is manageable if obesity drug demand accelerates to offset the production cuts. Bull case: hit $950 by year-end on GLP-1 momentum. Bear case: $880 if competition from Novo Nordisk intensifies.

AMD: Next catalyst is Q1 earnings on May 23. Need to hear more specifics on GPU market share gains. AI chip gross margins are crucial—if AMD is taking share at lower prices, the bear case (margin compression) wins.

How Pre-Market Trading Works

Pre-market trading begins at 4 a.m. ET and runs until the 9:30 a.m. ET open. Only institutional investors and active traders with access to electronic communication networks (ECNs) can trade. Volume is typically 10-20% of a stock's daily average. The benefit: early reaction to overnight news. The risk: illiquidity can cause exaggerated moves that fade or reverse at the open. Never chase a pre-market move without confirming it holds after the 9:30 a.m. bell—many pre-market rallies print gap reversals by 10 a.m.

Frequently Asked Questions

Q: Why do stocks move so much in pre-market trading?
A: Pre-market volume is thin (10-20% of daily average), meaning buy/sell imbalances create exaggerated percentage moves. A $5M buy order in pre-market can move a stock 3-5%, whereas the same $5M buy order during regular hours would move it 0.5-1%. The moves are real, but volatility is amplified by illiquidity.

Q: Should I trade pre-market movers?
A: Pre-market is high-risk for retail traders due to wide bid-ask spreads and low liquidity. Many pre-market rallies reverse at the open. For understanding volume and volatility, watch pre-market but wait for the 9:30 a.m. ET open to enter positions. This gives you real volume confirmation.

Q: What's the difference between pre-market and after-hours trading?
A: Pre-market runs 4 a.m.–9:30 a.m. ET. After-hours runs 4 p.m.–8 p.m. ET. Both have low volume and high spreads. Most institutional trading happens during regular hours (9:30 a.m.–4 p.m. ET).

Q: How do I access pre-market trading?
A: Most brokers offer pre-market trading if you have an active brokerage account. Check your broker's documentation. Interactive Brokers, TD Ameritrade, and Fidelity all support pre-market access for active traders.

Q: When do the biggest pre-market movers typically happen?
A: Between 7 a.m.–9:15 a.m. ET, as institutional traders position ahead of the open. Overnight news (earnings, FDA approvals, macro data) drives the earliest moves (4 a.m.–7 a.m.). Most volatility clusters 8:30 a.m.–9:15 a.m. as the open approaches.

Next Event: Regular market open at 9:30 a.m. ET on Monday, May 18, 2026. Follow live market coverage to see how these pre-market movers confirm or reverse at the bell. Check the earnings calendar for this week's scheduled reports (Pfizer, AMD, and Tesla earnings all hit May 22-28).